Financial Daily from THE HINDU group of publications
Tuesday, Oct 11, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Home Page - Pharmaceuticals
Industry & Economy - Natural Calamities


Drug cos keen to send relief to Pakistan

P.T. Jyothi Datta

"We are talking to the Pakistani High Commission and the Indian Ministry of External Affairs to work out what medicines are required and how it can be sent to people who need it, since currently, trade is not allowed between the two countries."

Mumbai, Oct. 10

THEY do not carry out direct business with each other during normal times. But drug companies in India are waiting in the wings to send relief in the form of medicines to Pakistan, where Saturday's earthquake left several thousands of people dead, injured and homeless.

"We are talking to the Pakistani High Commission and the Indian Ministry of External Affairs to work out what medicines are required and how it can be sent to people who need it, since currently, trade is not allowed between the two countries," said Mr D.G. Shah of the Indian Pharmaceutical Alliance (IPA).

The IPA is a platform of 13 domestic drug companies, including some of the biggest names in the Indian pharmaceutical sector such as Ranbaxy, Sun Pharma, Wockhardt, Dr Reddy's Laboratories and Lupin.

Medicines in Pakistan are about three to five times their price in India and Indian medicines have often made their way into the neighbouring market through porous borders. Some others procure medicines from India through more legal, though circuitous channels via Dubai or the UK. Still others send bulk drugs or ingredients that go into a medicine to Pakistan, but there is a high rate of duty, an industry representative said.

Meanwhile, within the country, Mumbai's Sun Pharma has a facility at Jammu. "Though there is no impact on our factory in Jammu, we remain very concerned about the general situation created due to the earthquake. We are coordinating with the local authorities to assist with medicines in this hour of calamity on humanitarian grounds," said Mr Dilip Sanghvi, Chairman and Managing Director of the company. But the trouble with sending relief, medicines in this case, to a disaster-struck region is that there is no coordinated effort or agency, said an industry representative, recalling similar experiences following the tsunami late last year.

The domestic drug industry is worth about Rs 30,000 crore and is capable and willing to send medicines in the times of disaster, he said, underlining the need for co-ordinated procurement and distribution.

An official with another domestic pharma industry association said he had not heard from the Centre on medicines needed in the quake-hit regions in Jammu and Kashmir, or across the border, though it is more than two days since the earthquake struck.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Tata Safari Dicor

Stories in this Section
Monsoon withdrawal resumes as `low' stays put


New Hyderabad airport to take off by March 2008
BPO players likely to merge: Forrester
To take on growing threat from IBM, Accenture

Kingfisher Airline looking to pick up stake in Air Sahara
Industrial growth prospects to spur metals demand
Drug cos keen to send relief to Pakistan
Now, small-time manufacturing units join outsourcing party
Oil cos moot coupons as LPG subsidy to BPL families
LIC in fray for taking over IFCI
Tom Schelling — Human touch to Game Theory


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line